Advertisement

Mitral Valve Disease

  • Corrado Tamburino
  • Gian Paolo Ussia

Abstract

Mitral stenosis is an obstruction of blood flow from the left atrium to the left ventricle. It is generally caused by rheumatic heart disease [1, 2]. Other causes of mitral stenosis are: severe calcification of the valve leaflets, congenital defects of the mitral valve, systemic lupus erythematosus (SLE), tumors, left atrial thrombi, vegetations due to endocarditis, and causes linked to prior device implants.

Keywords

Mitral Valve Left Atrium Mitral Regurgitation Coronary Sinus Pulmonary Capillary Wedge Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wood P. An appreciation of mitral stenosis-I. BMJ 1954;4870:1051–1063.Google Scholar
  2. 2.
    Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 2005;112:3584–3591.PubMedGoogle Scholar
  3. 3.
    Fae KC, Oshiro SE, Toubert A et al. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 2005;24:101–109.PubMedGoogle Scholar
  4. 4.
    Burge DJ, DeHoratious RJ. Acute rheumatic fever. Cardiovasc Clin 1993;23:3–23.PubMedGoogle Scholar
  5. 5.
    Guilherme L, Cury P, Demarchi LM et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004;165:1583–1591.PubMedGoogle Scholar
  6. 6.
    Davutoglu V, Celik A, Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis 2005;14:251–256.PubMedGoogle Scholar
  7. 7.
    Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am Heart J 1992; 123:1610–1632.PubMedGoogle Scholar
  8. 8.
    Spencer FC. A plea for early, open mitral commissurotomy. Am Heart J 1978;95:668–670.PubMedGoogle Scholar
  9. 9.
    Carabello BA. Timing of surgery in mitral and aortic stenosis. Cardiol Clin 1991;9:229–238.PubMedGoogle Scholar
  10. 10.
    Hygenholtz PG, Ryan TJ, Stein SW et al. The spectrum of pure mitral stenosis. Am J Cardiol 1962;10:773–784.Google Scholar
  11. 11.
    Arani DT, Carleton RA. The deleterious role of tachycardia in mitral stenosis. Circulation 1967;36:511–516.PubMedGoogle Scholar
  12. 12.
    Schofield PM. Invasive investigation of the mitral valve. In: Wells FC, Shapiro LM (eds) Mitral valve disease. Oxford: Butterworth-Heineman, 1996.Google Scholar
  13. 13.
    Kennedy JW, Yarnall SR, Murray JA et al. Quantitative angiocardiography: relationships of left atrial and ventricular pressure and volume in mitral valve disease. Circulation 1970;41:817–824.PubMedGoogle Scholar
  14. 14.
    Choi BW, Bacharach SL, Barcour DJ et al. Left ventricular systolic dysfunction: Diastolic filling characteristics and exercise cardiac reserve in mitral stenosis. Am J Cardiol 1995;75:526–529.PubMedGoogle Scholar
  15. 15.
    Braunwald E, Turi ZG. Pathophysiology of mitral valve disease. In: Wells FC, Shapiro LM (eds) Mitral valve dsease. Oxford: Butterworth-Heineman, 1996.Google Scholar
  16. 16.
    Thompson ME, Shaver JA, Leon DF. Effect of tachycardia on atrial transport in mitral stenosis. Am Heart J 1977;94:297–306.PubMedGoogle Scholar
  17. 17.
    Stott DK, Marpole DGF, Bristow JD et al. The role of left atrial transport in aortic and mitral stenosis. Circulation 1970;41:1031–1041.PubMedGoogle Scholar
  18. 18.
    Diker E, Aydogdu S, Ozdemir M et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 1996;77:96–98.PubMedGoogle Scholar
  19. 19.
    American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:1–148.Google Scholar
  20. 20.
    Vahanian A, Baumgartner H, Bax J et al. Task Force on the management of valvular heart disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230–268.PubMedGoogle Scholar
  21. 21.
    Braundwald E. Valvular heart disease. In: Braundwald E (ed) Heart disease. Philadelphia: WB Saunders, 1984; pp 1063–1135.Google Scholar
  22. 22.
    Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographic assessment of mitral stenosis. Circulation 1977;55:120–128.PubMedGoogle Scholar
  23. 23.
    Baumgartner H, Hung J, Bermejo J et al. Echocardiographic assessment of valve stenosis: EAE/ASE Recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1–23.PubMedGoogle Scholar
  24. 24.
    Messika-Zeitoun D, Brochet E, Holmin C et al. Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. Eur Heart J 2007;28:72–79.PubMedGoogle Scholar
  25. 25.
    Wilkins GT, Weyman AE, Abascal VM et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299–308.PubMedGoogle Scholar
  26. 26.
    Iung B, Cormier B, Ducimetiere P et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol 1996;27:407–414.PubMedGoogle Scholar
  27. 27.
    Rahimtoola SH, Durairaj A, Mehra A, Nuno I. Current evaluation and management of patients with mitral stenosis. Circulation 2002;106:1183–1188.PubMedGoogle Scholar
  28. 28.
    Iung B, Cormier B, Ducimetiere P et al. Immediate results of percutaneous mitral commissurotomy. Circulation 1996;94:2124–2130.PubMedGoogle Scholar
  29. 29.
    Reid CL, McKay CR, Chandraratna PA et al. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 1987;76:628–636.PubMedGoogle Scholar
  30. 30.
    Nishimura RA, Rihal CS, Tajik AJ, Holmes DR Jr. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol 1994;24:152–158.PubMedGoogle Scholar
  31. 31.
    Thomas JD, Newell JB, Choong CY, Weyman AE. Physical and physiological determinants of transmitral velocity: numerical analysis. Am J Physiol Heart Circ Physiol 1991;260:H1718–31.Google Scholar
  32. 32.
    Faletra F, Pezzano A Jr, Fusco R et al. Measurement of mitral valve area in mitral stenosis: four echocardiographic methods compared with direct measurement of anatomic orifices. J Am Coll Cardiol 1996;28:1190–1197.PubMedGoogle Scholar
  33. 33.
    Thomas JD, Weyman AE. Doppler mitral pressure half-time: a clinical tool in search of theoretical justification. J Am Coll Cardiol 1987;10:923–929.PubMedGoogle Scholar
  34. 34.
    Schwammenthal E, Vered Z, Agranat O et al. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation 2000;102:2378–2384.PubMedGoogle Scholar
  35. 35.
    Thomas JD, Wilkins GT, Choong CY et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation 1988;78:980–993.Google Scholar
  36. 36.
    Nakatani S, Masuyama T, Kodama K et al. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods. Circulation 1988;77:78–85.PubMedGoogle Scholar
  37. 37.
    Messika-Zeitoun D, Fung Yiu S, Cormier B et al. Sequential assessment of mitral valve area during diastole using colour M-mode flow convergence analysis: new insights into mitral stenosis physiology. Eur Heart J 2003;24:1244–1253.PubMedGoogle Scholar
  38. 38.
    Currie PJ, Seward JB, Chan KL et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Dopplercatheterization study in 127 patients. J Am Coll Cardiol 1985;6:750–756.PubMedGoogle Scholar
  39. 39.
    Braunwald E, Moscovitz HL, Mram SS et al. The hemodynamics of the left side of the heart as studied by simultaneous left atrial, left ventricular and aortic pressures; particular reference to mitral stenosis. Circulation 1955;12:69–81.PubMedGoogle Scholar
  40. 40.
    Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 1951;41:1–29.PubMedGoogle Scholar
  41. 41.
    Hugenholtz PG, Ryan TJ, Stein SW, Belmann WH. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability. Am J Cardiol 1962;10:773–784.PubMedGoogle Scholar
  42. 42.
    Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: ten-and twenty-year perspectives. Ann Intern Med 1960;52:741–749.PubMedGoogle Scholar
  43. 43.
    Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 1962;24:349–357.PubMedGoogle Scholar
  44. 44.
    Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation 1972;45:878–890.PubMedGoogle Scholar
  45. 45.
    Munoz S, Gallardo J, Diaz-Gorrin JR, Medina O. Influence of surgery on the natural history of rheumatic mitral and aortic valve disease. Am J Cardiol 1975;35:234–242.PubMedGoogle Scholar
  46. 46.
    Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br Heart J 1975;37:74–78.PubMedGoogle Scholar
  47. 47.
    Bonow RO, Carabello BA, Chatterjee K et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523–e661.PubMedGoogle Scholar
  48. 48.
    Himelman RB, Stulbarg M, Kircher B et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989;79:863–871.PubMedGoogle Scholar
  49. 49.
    Tamai J, Nagata S, Akaike M et al. Improvement in mitral flow dynamics during exercise after percutaneous transvenous mitral commissurotomy: noninvasive evaluation using continuous wave Doppler technique. Circulation 1990;81:46–51.PubMedGoogle Scholar
  50. 50.
    Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol 1991;17:1520–1526.PubMedGoogle Scholar
  51. 51.
    Cheriex EC, Pieters FA, Janssen JH et al. Value of exercise Doppler-echocardiography in patients with mitral stenosis. Int J Cardiol 1994;45:219–226.PubMedGoogle Scholar
  52. 52.
    Tamburino C, Russo G, Di Paola G et al. La valvuloplastica percutanea nella stenosi mitralica. Cardiologia 1993;38:7–17.PubMedGoogle Scholar
  53. 53.
    Iung B, Garbarz E, Michaud P et al. Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy: late efficacy and implications for patient selection. J Am Coll Cardiol, 2000;35:1295–1302.PubMedGoogle Scholar
  54. 54.
    Lip G, Wasfi MM, Hamil M et al. Percutaneous ballon valvuloplasty of stenosed mitral bioprosthesis. Int J Cardiol 1997;59:97–100.PubMedGoogle Scholar
  55. 55.
    Orbe LC, Sobrino N, Matè I et al. Effectiveness of balloon percutaneuos valvuloplasty for stenotic bioprosthetic valves in different positions. Am J Cardiol 1991;68:1719–1721.PubMedGoogle Scholar
  56. 56.
    Calvo OL, Sobrino N, Gamallo C et al. Balloon percutaneous valvuloplasty for stenotic bioprosthetic valves in the mitral position. Am J Cardiol 1987;60:736–737.PubMedGoogle Scholar
  57. 57.
    Spellberg RD, Mayeda GS, Flores JH. Balloon valvuloplasty of a stenosed mitral bioprosthesis. Am Heart J 1991;122:1785–1787.PubMedGoogle Scholar
  58. 58.
    Lin PJ, Chang JP, Chang CH. Balloon valvuloplasty is controindicated in stenotic mitral bioprosthesis. Am Heart J 1994;127:724–726.PubMedGoogle Scholar
  59. 59.
    Gupta A, Lokhandwala YY, Satoskar PR, Salvi VS. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes. J Am Coll Surg 1998;187:409–415.PubMedGoogle Scholar
  60. 60.
    Fawzy ME, Kinsara AJ, Stefadouros M et al. Long-term outcome of mitral balloon valvotomy in pregnant women. J Heart Valve Dis 2001;10:153–157.PubMedGoogle Scholar
  61. 61.
    Hameed A, Karaalp IS, Tummala PP et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893–899.PubMedGoogle Scholar
  62. 62.
    de Souza JA, Martinez EE Jr, Ambrose JA et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol 2001;37:900–903.PubMedGoogle Scholar
  63. 63.
    Cohen DJ, Kuntz RE, Gordon SP et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med 1992;327:1329–1335.PubMedGoogle Scholar
  64. 64.
    Kamalesh M, Burger AJ, Shubrooks SJ. The use of transesophageal echocardiography to avoid left atrial thrombus during percutaneous mitral valvuloplasty. Cathet Cardiovasc Diagn 1993;28:320–322.PubMedGoogle Scholar
  65. 65.
    Tsai LM, Hung JS, Chen JH et al. Resolution of left atrial appendage thrombus in mitral stenosis after warfarin therapy. Am Heart J 1991;121:1232–1234.PubMedGoogle Scholar
  66. 66.
    Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 1993;21:390–397.PubMedGoogle Scholar
  67. 67.
    Reid CL, McKay CR, Chandraratna PA et al. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 1987;76:628–636.PubMedGoogle Scholar
  68. 68.
    Palacios IF. Farewell to surgical mitral commissurotomy for many patients. Circulation 1998;97:223–226.PubMedGoogle Scholar
  69. 69.
    Palacios I, Block PC, Brandi S. Percutaneous ballon valvulotomy for patients with severe stenosis. Circulation 1987;75:778–784.PubMedGoogle Scholar
  70. 70.
    Davidson MJ, Baim DS. Percutaneous catheter-based mitral valve repair. Cohn LH (ed) Cardiac surgery in the adult. New York: McGraw-Hill, 2008; pp 1101–1108.Google Scholar
  71. 71.
    Marsocci G, Neri M, Natale N. Cardiopatie valvolari. Il Pensiero Scientifico Editore, Rome, 2004.Google Scholar
  72. 72.
    Inoue K. Percutaneous transvenous mitral commissurotomy using the Inoue balloon. Eur Heart J 1991;12:99–108.PubMedGoogle Scholar
  73. 73.
    Vahanian A, Acar J. Mitral valvuloplasty: the French experience. In: Topol EJ Textbook of interventional cardiology., Philadelphia: WB Saunders, 1994; pp 1206–1225.Google Scholar
  74. 74.
    Block PC, Palacios IF. Aortic and mitral balloon valvuloplasty: the United States experience. In: Topol EJ (ed) Textbook of interventional cardiology. Philadelphia: WB Saunders, 1994; pp 1189–1205.Google Scholar
  75. 75.
    Inoue K, Hungs JS. Percutaneous transvenous mitral commissurotomy (PTMC): the Far East experience. In: Topol EJ (Ed) Textbook of interventional cardiology. Philadelphia: WB Saunders, 1994; pp 1226–1242.Google Scholar
  76. 76.
    Tamburino C, Russo G, Calvi V et al. La valvuloplastica mitralica: risultati immediati e followup a 2 anni. Cardiologia 1993;38:367–375.PubMedGoogle Scholar
  77. 77.
    Ross JJr. Catheterization of the left heart through the interatrial septum: a new technique and its experimental evaluation. Surg Forum 1959;9:297–301.Google Scholar
  78. 78.
    Zaki AM, Kasem HH, Bakhoum S et al. Comparison of early results of percutaneous metallic mitral commissurotome with Inoue balloon technique in patients with high mitral echocardiographic scores. Catheter Cardiovasc Interv 2002;57:312–317.PubMedGoogle Scholar
  79. 79.
    Inoue K, Owaki T, Nakamura T et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87:394–402.PubMedGoogle Scholar
  80. 80.
    Baim DS. Grossman’s cardiac catheterization, angiography and intervention (7th edn). Philadelphia: Lippincott Williams and Wilkins, 2006.Google Scholar
  81. 81.
    Dean LS, Mickel M, Bonan R et al. Four-years follow up of patients undergoing percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. J Am Coll Cardiol 1996;28:1452.PubMedGoogle Scholar
  82. 82.
    Palacios IF, Tuzcu ME, Weyman AE et al. Clinical follow-up of patients undergoing percutaneous mitral balloon valvulotomy. Circulation 1995;91:671–676.PubMedGoogle Scholar
  83. 83.
    Pan M, Medina A, Lezo JJ et al. Factors determining late success after mitral balloon valvulotomy. Am J Cardiol 1993;71:1181–1186.PubMedGoogle Scholar
  84. 84.
    Arora R, Kalra GS, Murty GS et al. Percutaneous transatrial mitral commissurotomy: immediate and intermediate results. J Am Coll Cardiol 1994;23:1327–1332.PubMedGoogle Scholar
  85. 85.
    Palacios IF, Block PC, Wilkins GT, Weyman AE. Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. Circulation 1989;79:573–579.Google Scholar
  86. 86.
    Thomas MR, Monaghan MJ, Michalis LK, Jewitt DE. Echocardiographic restenosis after successful balloon dilatation of the mitral valve with the Inoue balloon: experience of a United Kingdom centre. Br Heart J 1993;69:418–423.PubMedGoogle Scholar
  87. 87.
    Iung B, Garbarz E, Michaud P et al. Immediate and midterm results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. Eur Heart J 2000;21:1683–1689.PubMedGoogle Scholar
  88. 88.
    Vahanian A, Palacios IF. Percutaneous approaches to valvular disease. Circulation 2004;109:1572–1579.PubMedGoogle Scholar
  89. 89.
    Fenster MS, Feldman MD. Mitral regurgitation: an overview. Curr Probl Cardiol 1995;20:193–280.PubMedGoogle Scholar
  90. 90.
    Luther RR, Meyers SN. Acute mitral insufficiency secondary to ruptured chordae tendineae. Arch Intern Med 1974;134:568.PubMedGoogle Scholar
  91. 91.
    Hansen DE, Sarris GE, Niczyporuk MA et al. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance. J Thorac Cardiovasc Surg 1989;97:521–533.PubMedGoogle Scholar
  92. 92.
    Yun KL, Niczyporuk MA, Sarris GE et al. Importance of mitral subvalvular apparatus in terms of cardiac energetics and systolic mechanics in the ejecting canine heart. J Clin Invest 1991;87:247–254.PubMedGoogle Scholar
  93. 93.
    Yiu SF, Enriquez-Sarano M, Tribouilloy C et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction. Circulation 2000;102:1400–1406.PubMedGoogle Scholar
  94. 94.
    Grigioni F, Enriquez-Sarano M, Zehr KJet al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001; 103:1759–1764.PubMedGoogle Scholar
  95. 95.
    Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875–883.PubMedGoogle Scholar
  96. 96.
    Waller BF, Howard J, Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation, part II. Clin Cardiol 1994;17:395–402.PubMedGoogle Scholar
  97. 97.
    Grossman W. Profiles in valvular heart disease. In: Baim DS, Grossman W (eds) Cardiac catheterization, angiography and intervention. Philadelphia: Lippincott Williams and Wilkins, 2006.Google Scholar
  98. 98.
    Ross J Jr. Adaptations of the left ventricle to chronic volume overload. Circ Res 1974;34–35.Google Scholar
  99. 99.
    Yun KL, Rayhill SC, Niczyporuk MA et al. Left ventricular mechanics and energetics in the dilated canine heart: acute versus chronic mitral regurgitation. J Thorac Cardiovasc Surg 1992;104:26–39.PubMedGoogle Scholar
  100. 100.
    Carabello BA, Nakano K, Corin W et al. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol Heart Circ Physiol 1989;256:H974–H981.Google Scholar
  101. 101.
    Urabe Y, Mann DL, Kent RL et al. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res 1992;70:131–147.PubMedGoogle Scholar
  102. 102.
    Starling MR, Kirsh MM, Montgomery DG et al. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 1993;22:239–250.PubMedGoogle Scholar
  103. 103.
    Nakano K, Swindle MM, Spinale F et al. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J Clin Invest 1991;87:2077–2086.PubMedGoogle Scholar
  104. 104.
    Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997;337:32–41.PubMedGoogle Scholar
  105. 105.
    Carabello BA, Nolan SP, McGuire LB. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981;64:1212–1217.PubMedGoogle Scholar
  106. 106.
    Carabello BA, Williams H, Gash AK et al. Hemodynamic predictors of outcome in patients undergoing valve replacement. Circulation 1986;74:1309–1316.PubMedGoogle Scholar
  107. 107.
    Grossman W, Braunwald E, Mann T et al. Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation 1977;56:845–852.PubMedGoogle Scholar
  108. 108.
    Borow KM, Green LH, Mann T et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 1980;68:655–663.PubMedGoogle Scholar
  109. 109.
    Carpentier A. Cardiac valve surgery: the French correction. J Thorac Cardiovasc Surg 1983;86:323–337.PubMedGoogle Scholar
  110. 110.
    Carpentier A, Chauvaud S, Fabiani J et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg 1980;79:338–348.PubMedGoogle Scholar
  111. 111.
    Wells FC. Conservation and surgical repair of the mitral valve. In: Wells FC, Shapiro LM (eds) Mitral valve disease. Oxford: Butterworth-Heineman, 1996.Google Scholar
  112. 112.
    Dagum P, Timek TA, Green GR et al. Coordinate-free analysis of mitral valve dynamics in normal and ischemic hearts. Circulation 2000;102:62–69.Google Scholar
  113. 113.
    Ngaage DL, Schaff HV. Mitral valve surgery in non-ischemic cardiomyopathy. J Cardiovasc Surg 2004;45:477–486.Google Scholar
  114. 114.
    Rahimtoola SH, Dell’Italia LJ. Mitral valve disease. In: Fuster V, Alexander RW, O’ Rourke RA et al Hurst’s The Heart (11th edn). New York: McGraw-Hill, 2004; pp1669–1695.Google Scholar
  115. 115.
    Zoghbi W.A, Eriquez-Sarano M, Foster E et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777–802.PubMedGoogle Scholar
  116. 116.
    Bargiggia GS, Tronconi L, Sahn DJ et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation 1991;84:1481–1489.PubMedGoogle Scholar
  117. 117.
    Simpson IA, Shiota T, Gharib M, Sahn DJ. Current status of flow convergence for clinical applications: is it a leaning tower of “PISA”? J Am Coll Cardiol 1996;27:504–509.PubMedGoogle Scholar
  118. 118.
    Baumgartner H, Schima H, Kuhn P. Value and limitations of proximal jet dimensions for the quantitation of valvular regurgitation: an in vitro study using Doppler flow imaging. J Am Soc Echocardiogr 1991;4:57–66.PubMedGoogle Scholar
  119. 119.
    Sahn DJ. Instrumentation and physical factors related to visualization of stenotic and regurgitant jets by Doppler color flow mapping. J Am Coll Cardiol 1988;12:1354–1365.PubMedGoogle Scholar
  120. 120.
    Pu M, Griffin BP, Vandervoort PM et al. The value of assessing pulmonary venous flow velocity for predicting severity of mitral regurgitation: a quantitative assessment integrating left ventricular function. J Am Soc Echocardiogr 1999;12:736–743.PubMedGoogle Scholar
  121. 121.
    Thomas L, Foster E, Schiller NB. Peak mitral inflow velocity predicts mitral regurgitation severity. J AmColl Cardiol 1998;31:174–179.Google Scholar
  122. 122.
    Braunwald E, Awe W. The syndrome of severe mitral regurgitation with normal left atrial pressure. Circulation 1963;27:29–35.PubMedGoogle Scholar
  123. 123.
    Tricon BH, Felker GM, Shaw LK et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic disfuncion and heart failure. Am J Cardiol 2003;91:538–543.Google Scholar
  124. 124.
    Tribouilloy CM, Enriquez-Sarano M, Schaff HV et al. Impact of preoperative symptoms on survival aftersurgical correction of organic mitral regurgitation: rationale for optimizing surgical implications. Circulation 1999;99:400–405.PubMedGoogle Scholar
  125. 125.
    Enriquez-Sarano M, Freeman WK, Tribouilloy et al. Functional anatomy of mitral regurgitation: accuracy and outcome implications of TEE. J Am Coll Cardiol 1999;34:1129–1136.PubMedGoogle Scholar
  126. 126.
    Thamilarasan M, Griffin B. Choosing the most appropriate valve operation and prosthesis. Cleveland Clin J Med 2002;69:668–703.Google Scholar
  127. 127.
    Lee EM, Shapiro LM, Wells FC. Superiority of mitral valve repair in surgery for degenerative mitral regurgitation. Eur Heart J 1997;18:655–663.PubMedGoogle Scholar
  128. 128.
    Enriquez-Sarano M, Schaff HV, Orszulak TA et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022–1028.Google Scholar
  129. 129.
    Pu M, Thomas JD, Gillinov MA, Griffin BP et al. Importance of ischaemic and viable myocardium for patients with chronic ischaemic mitral regurgitation and left ventricular dysfunction. Am J Cardiol 2003;92:862–864.PubMedGoogle Scholar
  130. 130.
    Roques F, Nashef SA, Michel P et al. EuroSCORE study group. Risk factor for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001;10:572–577.PubMedGoogle Scholar
  131. 131.
    Feldman T, Wasserman HS, Herrmann HC et al. Percutaneous mitral valve repair using the edge-to-edge technique six-month results of the EVEREST phase 1 clinical trial. J Am Coll Card 2006;46:2134–2140.Google Scholar
  132. 132.
    Silvestry FE, Rodriguez LL, Herrmann HC et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiog 2007;20:1131–1140.Google Scholar
  133. 133.
    Rohatgi S, Wasserman HS, Block PC et al. Mitral stenosis is not produced by percutaneous edge-to-edge repair of mitral regurgitation. Circulation 2005;112:520.Google Scholar
  134. 134.
    Herrmann HC, Kar S, Siegal R et al. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention 2009;4:437–442.PubMedGoogle Scholar
  135. 135.
    De Bonis M, Lapenna E, La Canna G et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy. Circulation 2005;112 (Suppl I):1402–1408.Google Scholar
  136. 136.
    Calafiore AM, Contini M, Iacò AL et al. Mitral valve repair for degenerative mitral regurgitation. J Cardiovasc Med 2008;8:114–118.Google Scholar
  137. 137.
    Foster E, Wasserman HS, Gray W et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100:1577–1583.PubMedGoogle Scholar
  138. 138.
    Maisano F, Schreuder JJ, Oppizzi M et al. The double-orifice technique as a standardized approach, to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur J Cardiothorac Surg 2000;17:201–205.PubMedGoogle Scholar
  139. 139.
    Herrmann HC, Wasserman HS, Whitlow P et al. Percutaneous edge-to-edge mitral valve repair using the Evalve MitraClip™ device: initial one-year results of the EVEREST phase 1 trial. Circulation 2005;112 (Suppl):520.Google Scholar
  140. 140.
    Mirabel M, Iung B, Baron G et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358–1365.PubMedGoogle Scholar
  141. 141.
    Piazza N, Asgar A, Ibrahim R, Bonan R. Transcatheter mitral and pulmonary valve therapy. J Am Coll Cardiol 2009;53:1837–1851.PubMedGoogle Scholar
  142. 142.
    Feldman T, Leon MB. Prospects for percutaneous valve therapies. Circulation 2007;116:2866–2877.PubMedGoogle Scholar
  143. 143.
    Lorusso R, Borghetti V, Totaro P, et al. The double-orifice technique for mitral valve reconstruction: predictors of outcome. Eur J Cardiothorac Surg 2001;20:583–589.PubMedGoogle Scholar
  144. 144.
    Bagai J, Zhao D. Subcutaneous “figure-of-eight” stitch to achieve hemostasis after removal of large-caliber femoral venous sheaths. Cardiac Interventions Today I 2008; July/August:22–23.Google Scholar
  145. 145.
    Alfieri O, Maisano F, DeBonis M et al. The edge-to-edge technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674–681.PubMedGoogle Scholar
  146. 146.
    Herrmann HC, Rohatgi S, Wasserman et al. Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip™ device for mitral regurgitation. Catheter Cardiovasc Interv 2006;68:821–828.PubMedGoogle Scholar
  147. 147.
    Condado JA, Acquatella H, Rodriguez L et al. Percutaneous edge-to-edge mitral valve repair: 2 year follow-up in the first human case. Catheter Cardiovasc Interv 2006;67:323–325.PubMedGoogle Scholar
  148. 148.
    Feldman T, Kar S, Rinaldi M et al. for the EVEREST investigators percutaneous mitral repair with the MitraClip system: safety and midterm durability in the Initial EVEREST (Endovascular Valve Edge-to-edge Repair Study) cohort. J Am Coll Cardiol 2009;54:686–694.PubMedGoogle Scholar
  149. 149.
    Dang NC, Aboodi MS, Sakaguchi T et al. Surgical revision after percutaneous mitral valve repair with a clip: initial multicenter experience. Ann Thorac Surg 2005;80:2338–2342.PubMedGoogle Scholar
  150. 150.
    Feldman T, Wasserman HS, Herrmann HC et al. Edge-to-edge mitral valve repair using the evalve MitraClip: one year results of the EVEREST phase I clinical trial. Am J Cardiol 2005;96 (Suppl 7A):49H.Google Scholar
  151. 150a.
    Feldman T. Endovascular Valve Edge-to-Edge REpair Study (EVEREST II) Randomized Clinical Trial: Primary Safety and Efficacy Endpoints. Presented at American College of Cardiology Congress, March 14, 2010, Atlanta.Google Scholar
  152. 151.
    Patrick L, Whitlow. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 21-25 September 2009, San Francisco.Google Scholar
  153. 152.
    Tamburino C, Ussia GP, Maisano F et al. Percutaneous mitral valve repair with the Mitraclip system: acute results from a real world setting. Eur Heart J 2010, epub ahead of print.Google Scholar
  154. 153.
    Scott Lim. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 21-25 September 2009, San Francisco.Google Scholar
  155. 153a.
    Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010, epub ahead of print.Google Scholar
  156. 154.
    Naqvi TZ, Zarbatany D, Molloy MD et al. Intracardiac echocardiography for percutaneous mitral valve repair in a swine model. J Am Soc Echocardiogr 2006;19:147–153.PubMedGoogle Scholar
  157. 155.
    Naqvi TZ, Buchbinder M, Zarbatany D et al. Beating-heart percutaneous mitral valve repair using a transcatheter endovascular suturing device in an animal model. Catheter Cardiovasc Interv 2007;69:525–531.PubMedGoogle Scholar
  158. 156.
    Grossi EA, Goldberg JD, La Pietra A et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg 2001;122:1107–1124.PubMedGoogle Scholar
  159. 157.
    Maniu CV, Patel JB, Reuter DG et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 2004;44(8):1652–1661.PubMedGoogle Scholar
  160. 158.
    Piazza N, Bonan R. Transcatheter mitral valve repair for functional mitral regurgitation: coronary sinus approach. J Interv Cardiol 2007;20:495–508.PubMedGoogle Scholar
  161. 159.
    Webb JG, Harnek J, Munt BI et al. Percutaneous transvenous mitral annuloplasty; initial human experience with device implantation in the coronary sinus. Circulation 2006;113:851–855.PubMedGoogle Scholar
  162. 160.
    Webb JG. MONARC Percutaneous transvenous mitral annuloplasty. Presented at Transcatheter Vale Therapies (TVT) Summit; 2009; Seattle.Google Scholar
  163. 161.
    Frerker C, Schäfer U, Schewel D et al. Percutaneous approaches for mitral valve interventions, a real alternative technique for standard cardiac surgery? Herz 2009;34:444–450.PubMedGoogle Scholar
  164. 162.
    Harnek J. 2-year interim results of the percutaneous MONARC™ system for the treatment of functional mitral regurgitation. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 21-25 September 2009, San Francisco.Google Scholar
  165. 163.
    Kaye DM, Byrne M, Alferness C, Power J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation. 2003;108:1795–1797.PubMedGoogle Scholar
  166. 164.
    Schofer J, Siminiak T, Haude M et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 2009;120:326–333.PubMedGoogle Scholar
  167. 165.
    Liddicoat JR, MacNeill BD, Gillinov AM et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 2003;60:410–416.PubMedGoogle Scholar
  168. 166.
    Daimon M, Shiota T, Gillinov AM et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time threedimensional echocardiographic study in an ovine model. Circulation 2005;111:2183–2189.PubMedGoogle Scholar
  169. 167.
    Dubreuil O, Basmadjian A, Ducharme A. et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter Cardiovasc Interv 2007;69:1053–1061.PubMedGoogle Scholar
  170. 168.
    Ellis S. Percutaneous mitral annuloplasty: Viacor PTOLEMY I update. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 2008, Washington DC.Google Scholar
  171. 169.
    Gillinov AM, Cosgrove DM, Blackstone EH et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116:734–743.PubMedGoogle Scholar
  172. 170.
    Tibayan FA Rodriguez F, Liang D et al. Paneth suture annuloplasty abolishes acute ischemic mitral regurgitation but preserves annular and leaflet dynamics. Circulation 2003;108:128–133.Google Scholar
  173. 171.
    Burr LH, Krayenbuhl C, Sutton MS. The mitral plication suture: a new technique of mitral valve repair. J Thorac Cardiovasc Surg 1977;73:589–595.PubMedGoogle Scholar
  174. 172.
    Nagy ZL, Peterffy A. Mitral annuloplasty with a suture technique. Eur J Cardiothoracic Surg 2000;18:739–741.Google Scholar
  175. 173.
    Buellesfeld L. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 21-25 September 2009, San Francisco.Google Scholar
  176. 174.
    Heuser RR, Witzel T, Dickens D, Takeda PA. Percutaneous treatment for mitral regurgitation: the QuantumCor system. J Interv Cardiol 2008;21:178–182.PubMedGoogle Scholar
  177. 175.
    Goel R, Witzel T, Dickens D et al. The quantumcor device for treating mitral regurgitation: an animal study. Catheter Cardiovasc Interv. 2009;74:43–48.PubMedGoogle Scholar
  178. 176.
    Heuser RR. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 21-25 September 2009, San Francisco.Google Scholar
  179. 177.
    Starksen N, Guided delivery system. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Congress, 2008.Google Scholar
  180. 178.
    Kono T, Sabbah HN, Rosman H et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20:1594–1598.PubMedGoogle Scholar
  181. 179.
    Sabbah HN, Rosman H, Kono T et al. On the mechanism of functional mitral regurgitation. Am J Cardiol. 1993;72:1074–1076.PubMedGoogle Scholar
  182. 180.
    Pedersen WR, Block PC, Feldman TE. The Coapsys Repair System for the percutaneous treatment of functional mitral insufficiency. Eurointervention 2006;1:A44–48.Google Scholar
  183. 181.
    Pedersen WR, Block P, Leon M et al. Coapsys mitral valve repair system: percutaneous implantation in an animal model. Catheter Cardiovasc Interv 2008;72:125–131.PubMedGoogle Scholar
  184. 182.
    Rogers JH, Macoviak JA, Rahdert DA et al. Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation 2006; 113;2329–2334.PubMedGoogle Scholar
  185. 183.
    Lozonschi L, Quaden R, Edwards NM et al. Transapical mitral valved stent implantation. Ann Thorac Surg 2008;86:745–748.PubMedGoogle Scholar
  186. 184.
    Herrmann HC. Transcatheter mitral valve implantation. The advantages of MIS-tMVI may make it the ideal choice for high-risk patients. Cardiac Interventions Today August/September 2009.Google Scholar
  187. 185.
    Maisano F, Michev I, Rowe S et al. Transapical endovascular implantation of neochordae using a suction and suture device. Eur J Cardiothorac Surg. 2009;36:118–122.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2010

Authors and Affiliations

  • Corrado Tamburino
    • 1
  • Gian Paolo Ussia
    • 2
  1. 1.Ferrarotto HospitalUniversity of Catania, ETNA FoundationCataniaItaly
  2. 2.Cardiology DivisionFerrarotto HospitalCataniaItaly

Personalised recommendations